Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.

Area of Science:

• Cardiology
• Medical Devices
• Clinical Trials

Background:

• Limited data exists on the impact of left ventricular (LV) lead positioning on long-term outcomes in cardiac resynchronization therapy with defibrillator (CRT-D) patients.
• Understanding lead location's role is crucial for optimizing CRT-D therapy effectiveness.

Purpose of the Study:

• To evaluate the association between left ventricular (LV) lead location and long-term clinical outcomes in patients participating in the Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
• To determine if specific LV lead positions correlate with reduced mortality and heart failure events.

Main Methods:

• Classified LV lead locations (apical, anterior, posterior/lateral) in 797 CRT-D patients, including those with left bundle branch block (LBBB) and non-LBBB.
• Assessed all-cause mortality and heart failure (HF) events using Kaplan-Meier and Cox proportional hazards analyses.
• Compared outcomes between CRT-D patients and 505 implantable cardioverter-defibrillator (ICD)-only patients.

Main Results:

• In CRT-D patients with LBBB, posterior/lateral LV lead placement was associated with significantly reduced long-term all-cause mortality (HR: 0.54) and HF events (HR: 0.44) compared to ICD-only therapy.
• Anterior LV lead placement in LBBB patients also reduced HF events (HR: 0.50) but not mortality.
• CRT-D therapy did not improve outcomes in non-LBBB patients, irrespective of LV lead location.

Conclusions:

• For mild heart failure patients with LBBB receiving CRT-D, posterior/lateral and anterior LV lead positions are associated with reduced HF or death events compared to ICD alone.
• The mortality benefit of CRT-D is specifically linked to posterior/lateral LV lead placement.
• Apical LV lead placement should be avoided due to increased early risk of death.